Zobrazeno 1 - 10
of 293
pro vyhledávání: '"I Morgado"'
Autor:
Carmen Lluch-Requerey, Miguel A. Montilla-Garrido, José I. Morgado-García de Polavieja, Álvaro Gragera-Martínez, Antonio Gómez-Menchero
Publikováno v:
Archivos de Cardiología de México, Vol 94, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/6d760e99ad014d2da5d88ab9a214b2b8
Autor:
Antonio Leon-Justel, Jose I. Morgado Garcia-Polavieja, Ana Isabel Alvarez-Rios, Francisco Jose Caro Fernandez, Pedro Agustin Pajaro Merino, Elena Galvez Rios, Ignacio Vazquez-Rico, Jose Francisco Diaz Fernandez
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-12 (2021)
Abstract Background Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide. Cardiac Biomarker is emerging as a novel tool for improving management of patients with HF with a reduced
Externí odkaz:
https://doaj.org/article/7f2ddb79e7164bc58a1394090d92384f
Autor:
José I. Morgado García-Polavieja, Andrea Sigismondi, Samuel Ortiz Cruces, Elena Gálvez Ríos, José Raúl López Aguilar, Ana J. Manovel Sánchez, Ana López Suárez, José Francisco Díaz Fernández
Publikováno v:
REC: CardioClinics. 57:172-181
Autor:
R Bravo Marques, V Becerra Munoz, A J Walls Rodriguez, F Espildora Hernandez, J L Callejas Rubio, J I Morgado Garcia De Polavieja, I Martin Suarez, J L Bonilla Palomas, F Rivas-Ruiz, A Recio Mayoral
Publikováno v:
European Heart Journal. 43
Background Pulmonary arterial hypertension (PAH) is a syndrome characterized by marked remodeling of the pulmonary vasculature and leading to right heart failure and death. Selexipag, an oral prostacyclin IP receptor agonist, has been shown to decrea
Autor:
Antonio, Leon-Justel, Jose I Morgado, Garcia-Polavieja, Ana Isabel, Alvarez-Rios, Ignacio, Vazquez-Rico, Alvaro Lopez-Masjuan, Rios, Adrian Rodriguez, Albarran, Elena Galvez, Rios, Jose F Diaz, Fernandez
Publikováno v:
Clinical Laboratory. 68
NT-proBNP is emerging as a novel tool for improving management of patients with heart failure (HF). The concept of health-related outcomes as the primary endpoint for therapeutic intervention in chronic disease, such as HF, should be the focal point
Publikováno v:
Informes de la Construccion, Vol 63, Iss Extra, Pp 61-71 (2011)
El trabajo se presenta con el objetivo de evaluar los beneficios de la incorporación de nuevas estrategias de gestión de agua en el medio urbano. Para ello se han tenido en cuenta los condicionantes urbanos y los hábitos de consumo de agua en las
Externí odkaz:
https://doaj.org/article/fa1fb77f1a1b44209a4ec0a47b1cfa01
Autor:
J.D. Leal del Ojo del Ojo, A.V. Quintero Salvago, I. Morgado Muñoz, J.J. Fedriani de Matos, L. Barrios Rodríguez
Publikováno v:
Revista Española de Anestesiología y Reanimación. 66:163-166
Resumen La enfermedad de McArdle o glucogenosis de tipo V es una miopatia metabolica rara que consiste en perdida muscular y debilidad. Los pacientes con esta enfermedad presentan riesgos asociados a la anestesia. Pueden presentar hipoglucemia, rabdo
Autor:
L. Barrios Rodríguez, J.D. Leal del Ojo del Ojo, I. Morgado Muñoz, J.J. Fedriani de Matos, A.V. Quintero Salvago
Publikováno v:
Revista Española de Anestesiología y Reanimación (English Edition). 66:163-166
McArdle disease or type V glycogenosis is a rare metabolic myopathy consisting of muscle loss and weakness. These patients have risks associated with anaesthesia. They can present with hypoglycaemia, rhabdomyolysis, acute renal failure, and electroly
Autor:
Jose I. Morgado Garcia-Polavieja, Ana Blanca Paloma Martínez Pérez, Jose Francisco Diaz Fernandez, Margarita Castillo Paredes, Francisco Javier Fernández López, Enrique López Herrero
Publikováno v:
Journal of Clinical Images and Medical Case Reports. 2
A 53-year-old man with a known allergy to metamizole presented for acute gonalgia, receiving metamizole by mistake. He suffers a severe allergy reaction accompanied by chest pain and signs of acute lower myocardial infarction, which subsides with tre
Autor:
Ana I. Alvarez-Rios, Elena Galvez Rios, Ignacio Vázquez-Rico, Pedro Agustin Pajaro Merino, Jose Francisco Diaz Fernandez, Jose I. Morgado Garcia-Polavieja, Francisco Jose Caro Fernandez, Antonio León-Justel
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-12 (2021)
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-12 (2021)
Background Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide. Cardiac Biomarker is emerging as a novel tool for improving management of patients with HF with a reduced left vent